Skip to main content

Gout

      RT @RHEUMarampa: DECT in #gout: color-coded lesions at MTP1 jt & patellar tendon exclusively pure MSU depositions. C

      sheila RHEUMarampa

      4 years 11 months ago
      DECT in #gout: color-coded lesions at MTP1 jt & patellar tendon exclusively pure MSU depositions. CCDL in gout: both pure MSU & calcium-containing depositios. @RheumNow #ACR20 Abs#0445 https://t.co/7zudk2muBR
      The RheumNow faculty reporters have been glued to their monitors all day, viewing video, reading and listening to abstract presentations and I charged them to earmark those presentations were the “Best” they saw today. Below is the list of most often noted #ACRbest abstracts from Day 1.
      RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by BMS, @HorizonNews , @SanofiGenzyme,

      Dr. John Cush RheumNow

      4 years 11 months ago
      RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by BMS, @HorizonNews , @SanofiGenzyme, @Novartis. All content chosen by RheumNow & its Faculty.
      Crystal Arthritis and Gout Highlights at ACR: Dr. Nicola Dalbeth

      Gout specialist Dr. Nicola Dalbeth from Aukland, New Zealand provides a preview perspective on crystal arthritis and gout studies and sessions at ACR 2020.

      Each pharmaceutical company has spent months and years preparing to present and highlight their featured clinical trials and abstracts at ACR 2020.  This is our selection of their best studies for you to review and evaluate as part of your to-do list.
      RT @drpnash: Long Term Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Chronic Gout: The Febuxostat

      Peter Nash drpnash

      4 years 11 months ago
      Long Term Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Chronic Gout: The Febuxostat versus Allopurinol Streamlined Trial (on Behalf of the FAST Investigators) https://t.co/LGERY3mpe5 #febuxostat #allopurinol #CVS some cardiac reassurance feboxustat
      The RECIPE Study - MMF in Refractory Gout: Dr. Jack Cush

      Dr. Jack Cush previews the RECIPE study, wherein MMF is used to blunt the immunogenicity of pegloticase (abstract #0952 presented at the ACR 2020 annual meeting). 

       

      Here is the last of our QD Clinics in Podcast form, just before we start ACR2020 coverage. In this compilation from the past week we talk about - HIV and arthritis - Hyperuricemia in PsA - An odd kind of dermatomyositis - Running out of options in Difficult RA Listen here or on your podcast program in your car.
      ×